Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (82)

Latest Posts

About This Stock More About This Stock
6 Best Stocks For Value Investors This Week – March 26, 2017
Article By: Benjamin Clark
Sunday, March 26, 2017 6:11 PM EDT
I evaluated 25 different companies and only 6 were found to be undervalued or fairly valued and suitable for Defensive and/or Enterprising Investors. Therefore, these companies are the best undervalued stocks of the week.
In this article: CVG, CVS, AMGN, CVCO, SYKE, CWB
Read
Ruling By FDA Causes Shares Of Esperion Therapeutics, Inc. To Jump 50% Today
Article By: Lorimer Wilson
Monday, March 20, 2017 3:23 PM EDT
Esperion announced this morning that the FDA is willing to sign off on an approval for its lead drug - provided it clears LDL lowering goals in a pivotal study - without a cardio study as a prerequisite. Its shares soared more than 50% on the news.
In this article: AMGN, ESPR
Read
Week In Review: BGI Genomics Plans $250 Million Shenzhen IPO
Article By: ChinaBio® Today
Saturday, March 18, 2017 1:45 PM EDT
BGI Genomics, the contract sequencing and diagnostics divisions of China genomics sequencing company BGI, filed to IPO on the Shenzhen Chi-Next exchange with a proposed target of raising $250 million.
In this article: PFE, AMGN
Read
AskSlim Market Week - Friday, March 17
Video By: Steve Miller
Friday, March 17, 2017 10:00 PM EDT
This was somewhat a typical FED week. S&P 500, the industrials, the Nasdaq, all have small gains for the week. Overall it was a quiet week.
In this video: AKS, NUE, UAL, ADBE, AMGN, BIIB, ORCL, SSYS, STLD, TSLA, WYNN, SPX
Watch
Amgen, Inc. Shares Plunge As Cholesterol Drug Not As Effective As Hoped
Article By: Lorimer Wilson
Friday, March 17, 2017 11:30 AM EDT
Amgen, Inc. shares plummeted 10% in Friday morning trading after the drug maker reported some positive findings about a key cholesterol drug that weren’t as good as many had hoped.
In this article: AMGN
Read

PARTNER HEADLINES

Latest Tweets for $AMGN

No tweets yet!